Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

gefitinib

  • You have access
    Targeted Treatment of HPV16-positive and -negative SCC Cells With Small Molecule Tyrosine Kinase Inhibitors and Everolimus Affects MMP2 and MMP14 Expression
    LENA HUBER, RICHARD BIRK, MANUEL KNUETTEL, NICOLE ROTTER, CHRISTOPH ADERHOLD, CLAUDIA SCHERL, ANNE LAMMERT, FREDERIC JUNGBAUER and BENEDIKT KRAMER
    Anticancer Research July 2022, 42 (7) 3403-3411; DOI: https://doi.org/10.21873/anticanres.15827
  • You have access
    Real-life Effectiveness of Afatinib Versus Gefitinib in Patients With Non-small-cell Lung Cancer: A Czech Multicentre Study
    MARTIN SVATON, MONIKA BRATOVA, ONDREJ FISCHER, JANA KREJCI, LEONA KOUBKOVA, MARKETA CERNOVSKA, MICHAL HRNCIARIK, MILADA ZEMANOVA, HELENA COUPKOVA, BEDRICH PORZER, DANIEL DOLEZAL, TANA TUZOVA, KAROLINA HURDALKOVA, MAGDA BARINOVA and JANA SKRICKOVA
    Anticancer Research April 2021, 41 (4) 2059-2065; DOI: https://doi.org/10.21873/anticanres.14975
  • You have access
    Apoptosis-related Proteins Are Altered by Selective Tyrosine Kinase Inhibitors and Everolimus in HPV-dependent SCC
    RICHARD BIRK, ANGELA SCHELL, CHRISTOPH ADERHOLD, STEPHAN HOCH, LENA HUBER, CORNELIA EMIKA MUELLER, ANNE LAMMERT, CLAUDIA SCHERL, NICOLE ROTTER, J. ULRICH SOMMER and BENEDIKT KRAMER
    Anticancer Research November 2020, 40 (11) 6195-6203; DOI: https://doi.org/10.21873/anticanres.14639
  • You have access
    Tyrosine Kinase Inhibitors and Everolimus Reduce IGF1R Expression in HPV16-positive and -negative Squamous Cell Carcinoma
    BENDIKT KRAMER, ANGELA SCHELL, CHRISTOPH ADERHOLD, LENA HUBER, C. EMIKA MUELLER, NICOLE ROTTER and RICHARD BIRK
    Anticancer Research July 2020, 40 (7) 3847-3855; DOI: https://doi.org/10.21873/anticanres.14374
  • You have access
    Effect of Small-molecule Tyrosine Kinase Inhibitors on PDGF-AA/BB and PDGFRα/β Expression in SCC According to HPV16 Status
    LENA HUBER, RICHARD BIRK, NICOLE ROTTER, CHRISTOPH ADERHOLD, ANNE LAMMERT, FREDERIC JUNGBAUER and BENEDIKT KRAMER
    Anticancer Research February 2020, 40 (2) 825-835; DOI: https://doi.org/10.21873/anticanres.14014
  • You have access
    Tetrandrine Increases the Sensitivity of Human Lung Adenocarcinoma PC14 Cells to Gefitinib by Lysosomal Inhibition
    EIKO SATO, SINYA OHTA, KENJIRO KAWAKAMI, MANA IKEDA, TATSUO TAKAHASHI, SHINJIRO KOBAYASHI and MASAAKI NOMURA
    Anticancer Research December 2019, 39 (12) 6585-6593; DOI: https://doi.org/10.21873/anticanres.13874
  • You have access
    Tyrosine Kinase Inhibitors Imatinib and Erlotinib Increase Apoptosis of Antimitotic Drug-resistant KBV20C Cells Without Inhibiting P-gp
    JI YEONG KIM, HYUNG SIK KIM and SUNGPIL YOON
    Anticancer Research July 2019, 39 (7) 3785-3793; DOI: https://doi.org/10.21873/anticanres.13527
  • You have access
    Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases
    KOICHI SARUWATARI, TOKUNORI IKEDA, SHO SAEKI, NAOKI SHINGU, KOSUKE IMAMURA, TAIYOU KOMATU, SUNAO USHIJIMA, HIROTAKA MARUYAMA, KOSUKE KASHIWABARA, YUSUKE TOMITA, HIDENORI ICHIYASU, KAZUHIKO FUJII and TAKURO SAKAGAMI
    Anticancer Research February 2019, 39 (2) 923-931; DOI: https://doi.org/10.21873/anticanres.13195
  • You have access
    Tyrosine Kinase Inhibition in HPV-related Squamous Cell Carcinoma Reveals Beneficial Expression of cKIT and Src
    BENEDIKT KRAMER, MARCEL KNEISSLE, RICHARD BIRK, NICOLE ROTTER and CHRISTOPH ADERHOLD
    Anticancer Research May 2018, 38 (5) 2723-2731;
  • You have access
    Phenethyl Isothiocyanate Induces Apoptotic Cell Death Through the Mitochondria-dependent Pathway in Gefitinib-resistant NCI-H460 Human Lung Cancer Cells In Vitro
    TE-CHUN HSIA, YI-PING HUANG, YI-WEN JIANG, HSIN-YU CHEN, ZHENG-YU CHENG, YUNG-TING HSIAO, CHENG-YEN CHEN, SHU-FEN PENG, FU-SHIN CHUEH, YU-CHENG CHOU and JING-GUNG CHUNG
    Anticancer Research April 2018, 38 (4) 2137-2147;

Pages

  • Next
  • 1
  • 2
  • 3
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire